Top Zolpidem Brands: Ultimate Sleep Companions!

Finding the right medication for sleep disorders can be crucial for achieving a restful night. Zolpidem, commonly used for short-term management of insomnia, is available under various reputable brand names, each offering their own formulation and benefits. Popular brands like Ambien, Stilnox, and Edluar are frequently recommended by healthcare professionals for their efficacy. To help you make an informed choice, explore the detailed breakdown of the top zolpidem brands below.

Illustration of zolpidem

Best brands of zolpidem in 2025

Ambien

Ambien, initially approved in 1992, is a brand name for zolpidem, a non-benzodiazepine hypnotic medication, and while it once held a significant market share with sales reaching $2 billion, the introduction of generic versions in 2007 caused Ambien's market share to drop from 92% to 28% within a month. Although its sales were $39 million for the 12 months ending April 2024, it remains a widely recognized name for zolpidem. You can find more information about the product on their website.

Edluar

Edluar, a brand of zolpidem tartrate sublingual tablets, was FDA approved in 2009 and is manufactured by Mylan Speciality LP, offering a fast-acting solution for short-term insomnia characterized by difficulty falling asleep, using a sublingual formulation for quick absorption with available strengths of 5mg and 10mg. It is a controlled substance, and is generally recommended for short-term use due to potential tolerance and dependence. Edluar provides an alternative to traditional oral tablets and is indicated for short-term treatment of insomnia, helping individuals fall asleep faster. The medication should be taken immediately before bedtime, with a full 7-8 hours dedicated to sleep.

Intermezzo

Intermezzo, a brand of zolpidem tartrate sublingual tablets, is designed for middle-of-the-night insomnia, with the FDA approving it in 2011. It comes in 1.75 mg doses for women and 3.5 mg doses for men, as women process the drug at a slower rate, and it should be taken only when at least 4 hours of sleep remain; it is a fast-acting medication, achieving maximum concentration in the blood within 35-75 minutes. The medication is a Schedule IV controlled substance due to the potential for misuse and dependence, and is intended to be placed under the tongue to dissolve completely and not to be taken with food for optimal absorption, but it should be noted that the original brand has been discontinued, and generic versions are available. You can find more information about zolpidem on this website.

Stilnox

Stilnox, containing zolpidem tartrate, is a brand used for initiating and maintaining sleep, and is not recommended for use longer than 4 weeks. Sanofi Winthrop Industrie manufactures Stilnox, which works by binding to specific sites in the brain to induce sleep, and it is available in both immediate and extended-release forms. While market share data from 2007-2008 shows generic zolpidem options gaining popularity, Stilnox remains a recognizable brand for this medication. A boxed warning for zolpidem highlights potential complex sleep-related behaviors. You can find more information about Stilnox on the Sanofi website.

Zolpimist

Zolpimist, an oral spray formulation of zolpidem tartrate developed by NovaDel Pharma, was FDA-approved in 2008 for short-term insomnia treatment. It offers a fast-acting alternative with a 10-minute onset compared to 30-40 minutes for tablets, utilizing a unique buccal delivery system. While zolpidem holds approximately a 70% market share for insomnia medication, it's important to be aware of potential complex sleep behaviors as a side effect. For more information, please visit the NovaDel Pharma official website.

Sanval

Sanval, a brand of zolpidem, is recognized as an effective option for managing insomnia, with studies showing it improves sleep patterns by decreasing the time to fall asleep, reducing awakenings, and increasing the duration of delta sleep. Sanval is manufactured by Sanval Comercio e Industria, founded in 1966, and is known for its high safety and tolerability profile; it is available in various formulations, including 10mg tablets. Though other manufacturers also produce zolpidem, Sanval remains a popular option in various countries and is sold under different brand names in different locations. It is important to use zolpidem under the guidance of a healthcare professional due to potential side effects and interactions with other medications. For further details, you can explore their offerings through their official website.

Hypnogen

Hypnogen, a well-established hypnotic brand acquired by Nycomed in 2009, is a producer of zolpidem, a nonbenzodiazepine medication available in 5 and 10 mg tablets, known for its rapid absorption and short elimination half-life for the short-term treatment of insomnia. While it shares similar hypnotic effects to benzodiazepines, Hypnogen is chemically distinct as an imidazopyridine, making it a popular choice. It is also marketed under various names like Stilnoct and Ambien, with dosages varying based on individual needs, especially between men and women due to differing clearance rates. For more information about Hypnogen and other zolpidem brands, please visit the link.

Sublinox

Sublinox, produced by Bausch Health Canada Inc., is a brand of zolpidem available in 10 mg orally disintegrating sublingual tablets, approved in Canada since 2011 for short-term insomnia treatment, offering rapid onset of action to help with falling asleep, though its effectiveness may decrease with regular use, and is generally recommended for no more than 7-10 consecutive days due to potential side effects such as dizziness and next-day drowsiness. You can find more information about Sublinox at the Bausch Health Canada website.

Tovalt ODT

Tovalt ODT, approved by the FDA in 2007, is a brand of zolpidem tartrate available in 5mg and 10mg orally disintegrating tablets, designed for short-term insomnia treatment. This medication demonstrates a 103% bioavailability compared to immediate-release formulations and effectively decreases sleep latency for up to 35 days in clinical studies. A mean zolpidem Cmax of 101.68 ng/mL is typically achieved approximately 1.75 hours after a 10mg dose, with 92.5% protein binding. For detailed information about Tovalt ODT, please visit the FDA website.

Oneiro

While Oneiro is mentioned as a chemical company, there is no indication that it is a major producer of zolpidem. However, zolpidem, initially approved in 1992, is a widely used medication for short-term insomnia treatment, with an estimated market share of around 70% at one point and over 1.2 billion tablets prescribed in the US in 2010. This non-benzodiazepine hypnotic is available in various forms, such as tablets, sublingual tablets, and oral sprays, and it has been shown to decrease the time it takes to fall asleep by approximately 15 minutes and helps people stay asleep longer at higher doses, with an onset of action within 30 minutes. Although generally considered effective, it is important to note that adverse reactions, including neuropsychiatric effects, have been reported. For more detailed information, visit the official Cosette Pharmaceuticals website.